Wikipedia

Eucorvac-19

EuCorVac-19 är ett COVID-19-vaccin som utvecklats av EuBiologics Co.[1][2][3][4][5]

Referenser redigera

  1. ^ ”Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults”. clinicaltrials.gov. United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04783311. 
  2. ^ ”EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea”. Business Wire. 21 January 2021. https://www.businesswire.com/news/home/20210121005311/en/EuBiologics-Gets-an-IND-Approval-for-Phase-III-Clinical-Trial-of-EuCorVac-19-in-Korea. 
  3. ^ Moon-hee, Choi (21 January 2021). ”EuBiologics Wins Approval on Clinical Trial of COVID-19 Vaccine 'EuCOVAC-19'”. Business Korea. http://www.businesskorea.co.kr/news/articleView.html?idxno=58933. 
  4. ^ ”EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea”. EuBiologics. 21 January 2021. http://www.eubiologics.com/eng/sub4_2_view.php?idx=13&page_number=1&mode=&search_gubun=all&search_keyword=. 
  5. ^ ”Firm looks to build vaccine manufacturing plant in PH” (på engelska). ABS-CBN News. 12 April 2021. https://news.abs-cbn.com/business/04/12/21/firm-looks-to-build-vaccine-manufacturing-plant-in-ph. 
Hämtad från ”https://sv.wikipedia.org/w/index.php?title=Eucorvac-19&oldid=50078218”